Cargando…

miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia

Acute myeloid leukemia (AML) is a hematological malignancy characterized by the impaired differentiation and uncontrolled proliferation of myeloid blasts. Tumor suppressor p53 is often downregulated in AML cells via ubiquitination-mediated degradation. While the role of E3 ligase MDM2 in p53 ubiquit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Han Zhong, Peng, Zhiyong, Zhuang, Xiaomei, Wang, Xiaobo, Lu, Bo, Guo, Yao, Zhao, Yuming, Zhang, Dengyang, Xiao, Yunjun, Gao, Tianshun, Yu, Liuting, He, Chunxiao, Wu, Shunjie, Baek, Suk-Hwan, Zhao, Zhizhuang Joe, Xu, Xiaojun, Chen, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349814/ https://www.ncbi.nlm.nih.gov/pubmed/37454155 http://dx.doi.org/10.1038/s41420-023-01537-4

Ejemplares similares

Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017)

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
por: Shao, Xuejing, et al.
Publicado: (2022)

Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML
por: Zhao, Yuming, et al.
Publicado: (2023)

Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma
por: Wu, Yue, et al.
Publicado: (2023)

Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway
por: Park, Sang-Soo, et al.
Publicado: (2023)

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

Role of MicroRNAs-221/222 in Digestive Systems
por: Matsuzaki, Juntaro, et al.
Publicado: (2015)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Genistein Promotes Skeletal Muscle Regeneration by Regulating miR-221/222
por: Shen, Linyuan, et al.
Publicado: (2022)

Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
por: Song, Jialin, et al.
Publicado: (2017)

Development of a highly sensitive method for detection of FLT3D835Y
por: Guo, Yao, et al.
Publicado: (2020)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
por: Gui, Bin, et al.
Publicado: (2017)

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
por: Rommer, Anna, et al.
Publicado: (2013)

Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling
por: Chistiakov, Dmitry A., et al.
Publicado: (2015)

Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model
por: Choi, Boram, et al.
Publicado: (2017)

Role of miR-221/222 in Tumor Development and the Underlying Mechanism
por: Song, Qian, et al.
Publicado: (2019)

Influence of miR-221/222 on cardiomyocyte calcium handling and function
por: Knyrim, Maria, et al.
Publicado: (2021)

Identification of targets of miRNA-221 and miRNA-222 in fulvestrant-resistant breast cancer
por: Liu, Pengfei, et al.
Publicado: (2016)

Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
por: Zhang, Dengyang, et al.
Publicado: (2022)

Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells
por: Cardinali, Beatrice, et al.
Publicado: (2009)

miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
por: Quintavalle, Cristina, et al.
Publicado: (2013)

Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression
por: Zhang, Dengyang, et al.
Publicado: (2021)

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies
por: Yu, Liuting, et al.
Publicado: (2021)

THE DIMENSIONS OF YOUNG ONSET DEMENTIA (YOD) AND WHAT THESE MEAN FOR EXTENDED WORKING LIVES
por: Taylor, Philip
Publicado: (2022)

miRNA-221 and miRNA-222 synergistically function to promote vascular calcification
por: Mackenzie, N C W, et al.
Publicado: (2014)

Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice
por: Jiang, Xiuli, et al.
Publicado: (2018)

MicroRNA 221/222 cluster kicks out Timp-3 to inflame the liver
por: Menghini, Rossella, et al.
Publicado: (2018)

miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer
por: Li, Yuan, et al.
Publicado: (2014)

miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells
por: Liu, Wenneng, et al.
Publicado: (2015)

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
por: Zhang, Chun-Zhi, et al.
Publicado: (2010)

In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
por: Di Martino, Maria Teresa, et al.
Publicado: (2013)

miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
por: Xu, Qinhong, et al.
Publicado: (2015)

Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis
por: Xiao, Xi, et al.
Publicado: (2021)

Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN
por: Zhou, Lijie, et al.
Publicado: (2016)

Reck-Notch1 Signaling Mediates miR-221/222 Regulation of Lung Cancer Stem Cells in NSCLC
por: Guo, Yuefan, et al.
Publicado: (2021)

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
por: Mercatelli, Neri, et al.
Publicado: (2008)

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
por: Zhang, Chunzhi, et al.
Publicado: (2012)

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
por: Falkenberg, N, et al.
Publicado: (2013)

HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer
por: Mardente, S., et al.
Publicado: (2015)

Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
por: Cerda, Alvaro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ftebc57s6ukp1jn2jao6bj0p9l